Literature DB >> 19528207

Antigen-specific memory B-cell responses to Vibrio cholerae O1 infection in Bangladesh.

Aaron M Harris1, M Saruar Bhuiyan, Fahima Chowdhury, Ashraful I Khan, Azim Hossain, Emily A Kendall, Atiqur Rahman, Regina C LaRocque, Jens Wrammert, Edward T Ryan, Firdausi Qadri, Stephen B Calderwood, Jason B Harris.   

Abstract

Cholera, caused by Vibrio cholerae, is a noninvasive dehydrating enteric disease with a high mortality rate if untreated. Infection with V. cholerae elicits long-term protection against subsequent disease in countries where the disease is endemic. Although the mechanism of this protective immunity is unknown, it has been hypothesized that a protective mucosal response to V. cholerae infection may be mediated by anamnestic responses of memory B cells in the gut-associated lymphoid tissue. To characterize memory B-cell responses to cholera, we enrolled a cohort of 39 hospitalized patients with culture-confirmed cholera and evaluated their immunologic responses at frequent intervals over the subsequent 1 year. Memory B cells to cholera antigens, including lipopolysaccharide (LPS), and the protein antigens cholera toxin B subunit (CTB) and toxin-coregulated pilus major subunit A (TcpA) were enumerated using a method of polyclonal stimulation of peripheral blood mononuclear cells followed by a standard enzyme-linked immunospot procedure. All patients demonstrated CTB, TcpA, and LPS-specific immunoglobulin G (IgG)and IgA memory responses by day 90. In addition, these memory B-cell responses persisted up to 1 year, substantially longer than other traditional immunologic markers of infection with V. cholerae. While the magnitude of the LPS-specific IgG memory B-cell response waned at 1 year, CTB- and TcpA-specific IgG memory B cells remained significantly elevated at 1 year after infection, suggesting that T-cell help may result in a more durable memory B-cell response to V. cholerae protein antigens. Such memory B cells could mediate anamnestic responses on reexposure to V. cholerae.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19528207      PMCID: PMC2738048          DOI: 10.1128/IAI.00369-09

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  Cutting edge: long-term B cell memory in humans after smallpox vaccination.

Authors:  Shane Crotty; Phil Felgner; Huw Davies; John Glidewell; Luis Villarreal; Rafi Ahmed
Journal:  J Immunol       Date:  2003-11-15       Impact factor: 5.422

2.  Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system.

Authors:  Shane Crotty; Rachael D Aubert; John Glidewell; Rafi Ahmed
Journal:  J Immunol Methods       Date:  2004-03       Impact factor: 2.303

3.  Lipopolysaccharide- and cholera toxin-specific subclass distribution of B-cell responses in cholera.

Authors:  F Qadri; F Ahmed; M M Karim; C Wenneras; Y A Begum; M Abdus Salam; M J Albert; J R McGhee
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

4.  Duration of infection-derived immunity to cholera.

Authors:  M M Levine; R E Black; M L Clements; L Cisneros; D R Nalin; C R Young
Journal:  J Infect Dis       Date:  1981-06       Impact factor: 5.226

5.  Magnitude, kinetics, and duration of vibriocidal antibody responses in North Americans after ingestion of Vibrio cholerae.

Authors:  M L Clements; M M Levine; C R Young; R E Black; Y L Lim; R M Robins-Browne; J P Craig
Journal:  J Infect Dis       Date:  1982-04       Impact factor: 5.226

6.  The major subunit of the toxin-coregulated pilus TcpA induces mucosal and systemic immunoglobulin A immune responses in patients with cholera caused by Vibrio cholerae O1 and O139.

Authors:  Muhammad Asaduzzaman; Edward T Ryan; Manohar John; Long Hang; Ashraful I Khan; A S G Faruque; Ronald K Taylor; Stephen B Calderwood; Firdausi Qadri
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

Review 7.  Cholera.

Authors:  David A Sack; R Bradley Sack; G Balakrish Nair; A K Siddique
Journal:  Lancet       Date:  2004-01-17       Impact factor: 79.321

8.  Antigen-specific immunoglobulin A antibodies secreted from circulating B cells are an effective marker for recent local immune responses in patients with cholera: comparison to antibody-secreting cell responses and other immunological markers.

Authors:  Firdausi Qadri; Edward T Ryan; A S G Faruque; Firoz Ahmed; Ashraful Islam Khan; M Monirul Islam; Syed M Akramuzzaman; David A Sack; Stephen B Calderwood
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

9.  Incomplete correlation of serum vibriocidal antibody titer with protection from Vibrio cholerae infection in urban Bangladesh.

Authors:  Debasish Saha; Regina C LaRocque; Ashraful I Khan; Jason B Harris; Yasmin Ara Begum; Syed M Akramuzzaman; Abu S G Faruque; Edward T Ryan; Firdausi Qadri; Stephen B Calderwood
Journal:  J Infect Dis       Date:  2004-05-25       Impact factor: 5.226

10.  Cholera toxin-specific memory B cell responses are induced in patients with dehydrating diarrhea caused by Vibrio cholerae O1.

Authors:  Channa R Jayasekera; Jason B Harris; Saruar Bhuiyan; Fahima Chowdhury; Ashraful I Khan; Abu S G Faruque; Regina C Larocque; Edward T Ryan; Rafi Ahmed; Firdausi Qadri; Stephen B Calderwood
Journal:  J Infect Dis       Date:  2008-10-01       Impact factor: 5.226

View more
  72 in total

1.  Memory B cell and other immune responses in children receiving two doses of an oral killed cholera vaccine compared to responses following natural cholera infection in Bangladesh.

Authors:  Daniel T Leung; Mohammad Arif Rahman; M Mohasin; Sweta M Patel; Amena Aktar; Farhana Khanam; Taher Uddin; M Asrafuzzaman Riyadh; Amit Saha; Mohammad Murshid Alam; Fahima Chowdhury; Ashraful Islam Khan; Richelle Charles; Regina LaRocque; Jason B Harris; Stephen B Calderwood; Firdausi Qadri; Edward T Ryan
Journal:  Clin Vaccine Immunol       Date:  2012-03-21

2.  Lipopolysaccharide-specific memory B cell responses to an attenuated live cholera vaccine are associated with protection against Vibrio cholerae infection.

Authors:  Douglas J Haney; Michael D Lock; Marc Gurwith; Jakub K Simon; Glenn Ishioka; Mitchell B Cohen; Beth D Kirkpatrick; Caroline E Lyon; Wilbur H Chen; Marcelo B Sztein; Myron M Levine; Jason B Harris
Journal:  Vaccine       Date:  2018-04-11       Impact factor: 3.641

3.  Antigen-specific memory B-cell responses in Bangladeshi adults after one- or two-dose oral killed cholera vaccination and comparison with responses in patients with naturally acquired cholera.

Authors:  Mohammad Murshid Alam; M Asrafuzzaman Riyadh; Kaniz Fatema; Mohammad Arif Rahman; Nayeema Akhtar; Tanvir Ahmed; Mohiul Islam Chowdhury; Fahima Chowdhury; Stephen B Calderwood; Jason B Harris; Edward T Ryan; Firdausi Qadri
Journal:  Clin Vaccine Immunol       Date:  2011-02-23

4.  Mucosal immunologic responses in cholera patients in Bangladesh.

Authors:  Taher Uddin; Jason B Harris; Taufiqur Rahman Bhuiyan; Tahmina Shirin; Muhammad Ikhtear Uddin; Ashraful Islam Khan; Fahima Chowdhury; Regina C LaRocque; Nur Haque Alam; Edward T Ryan; Stephen B Calderwood; Firdausi Qadri
Journal:  Clin Vaccine Immunol       Date:  2011-01-19

5.  Insights from natural infection-derived immunity to cholera instruct vaccine efforts.

Authors:  Marcela F Pasetti; Myron M Levine
Journal:  Clin Vaccine Immunol       Date:  2012-09-19

6.  Antigen-specific memory T cell responses after vaccination with an oral killed cholera vaccine in Bangladeshi children and comparison to responses in patients with naturally acquired cholera.

Authors:  Mohammad Arifuzzaman; Rasheduzzaman Rashu; Daniel T Leung; M Ismail Hosen; Taufiqur Rahman Bhuiyan; M Saruar Bhuiyan; Mohammad Arif Rahman; Farhana Khanam; Amit Saha; Richelle C Charles; Regina C LaRocque; Ana A Weil; John D Clements; Randall K Holmes; Stephen B Calderwood; Jason B Harris; Edward T Ryan; Firdausi Qadri
Journal:  Clin Vaccine Immunol       Date:  2012-06-27

7.  Immune responses to O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 Ogawa in adult Bangladeshi recipients of an oral killed cholera vaccine and comparison to responses in patients with cholera.

Authors:  Taher Uddin; Amena Aktar; Peng Xu; Russell A Johnson; M Arifur Rahman; Daniel T Leung; Sadia Afrin; Aklima Akter; Mohammad Murshid Alam; Atiqur Rahman; Fahima Chowdhury; Ashraful I Khan; Taufiqur Rahman Bhuiyan; Meagan K Bufano; Rasheduzzaman Rashu; Yanan Yu; Ying Wu-Freeman; Jason B Harris; Regina C LaRocque; Richelle C Charles; Pavol Kováč; Stephen B Calderwood; Edward T Ryan; Firdausi Qadri
Journal:  Am J Trop Med Hyg       Date:  2014-03-31       Impact factor: 2.345

Review 8.  Maximizing protection from use of oral cholera vaccines in developing country settings: an immunological review of oral cholera vaccines.

Authors:  Sachin N Desai; Alejandro Cravioto; Dipika Sur; Suman Kanungo
Journal:  Hum Vaccin Immunother       Date:  2014-05-26       Impact factor: 3.452

Review 9.  Mucosal immunity to pathogenic intestinal bacteria.

Authors:  Araceli Perez-Lopez; Judith Behnsen; Sean-Paul Nuccio; Manuela Raffatellu
Journal:  Nat Rev Immunol       Date:  2016-02-22       Impact factor: 53.106

10.  The Plasmodium falciparum-specific human memory B cell compartment expands gradually with repeated malaria infections.

Authors:  Greta E Weiss; Boubacar Traore; Kassoum Kayentao; Aissata Ongoiba; Safiatou Doumbo; Didier Doumtabe; Younoussou Kone; Seydou Dia; Agnes Guindo; Abdramane Traore; Chiung-Yu Huang; Kazutoyo Miura; Marko Mircetic; Shanping Li; Amy Baughman; David L Narum; Louis H Miller; Ogobara K Doumbo; Susan K Pierce; Peter D Crompton
Journal:  PLoS Pathog       Date:  2010-05-20       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.